US Patent 8075884 Antibodies to OX-2/CD200 and uses thereof
Patent 8075884 was granted and assigned to Alexion Pharmaceuticals, Inc. on December, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+119 characters)
Article
Patent abstract
This application provides methods and compositions for modulating and/or depleting CD200 positive cells.
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Anke Kretz-Rommel0
Dayang Wu0
Jeremy P. Springhorn0
Katherine S. Bowdish0
Susan Faas McKnight0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08075884 Antibodies to OX-2/CD200 and uses thereof US Patent 8075884 Antibodies to OX-2/CD200 and uses thereof
Infobox
Patent Number
080758840
Patent Number
80758840
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
080758840
Date of Patent
December 13, 2011
0Patent Application Number
120876830
Date Filed
January 11, 2007
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08075884 Antibodies to OX-2/CD200 and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08075884
Date of patent
December 13, 2011
Patent application number
12087683
Date Filed
January 11, 2007
Patent primary examiner
Find more entities like US Patent 8075884 Antibodies to OX-2/CD200 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
